$BLTE
BELITE BIO, INC

2022 Q4 Form 20-F Financial Statement

#000110465923040145 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.952M $3.952M $2.378M
YoY Change 66.19% 66.19% 15.72%
% of Gross Profit
Research & Development $8.869M $8.869M $7.419M
YoY Change 19.54% 19.54% 101.17%
% of Gross Profit
Depreciation & Amortization $64.00K $15.00K
YoY Change 113.33% 66.67%
% of Gross Profit
Operating Expenses $12.82M $12.82M $9.797M
YoY Change 30.87% 30.87% 70.59%
Operating Profit -$12.82M
YoY Change 30.87%
Interest Expense $173.0K $16.00K $131.0K
YoY Change 32.06% -87.79% -1555.56%
% of Operating Profit
Other Income/Expense, Net $173.0K
YoY Change 32.06%
Pretax Income -$12.65M -$12.65M -$9.666M
YoY Change 30.85% 30.85% 68.05%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$12.65M -$12.60M -$9.666M
YoY Change 30.85% 30.35% 68.02%
Net Earnings / Revenue
Basic Earnings Per Share -$0.63
Diluted Earnings Per Share -$0.63 -$0.63 -$401.2K
COMMON SHARES
Basic Shares Outstanding 24.90M 19.98M
Diluted Shares Outstanding 19.98M

Balance Sheet

Concept 2022 Q4 2022 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $42.09M $42.09M $17.34M
YoY Change 142.67% 142.67%
Cash & Equivalents $42.10M $17.34M
Short-Term Investments
Other Short-Term Assets $699.0K $699.0K $64.00K
YoY Change 992.19% 992.19%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $42.81M $42.81M $17.43M
YoY Change 145.58% 145.58%
LONG-TERM ASSETS
Property, Plant & Equipment $541.0K $1.347M $94.00K
YoY Change 475.53% 1332.98%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $119.0K $119.0K $823.0K
YoY Change -85.54% -85.54%
Total Long-Term Assets $1.466M $1.466M $917.0K
YoY Change 59.87% 59.87%
TOTAL ASSETS
Total Short-Term Assets $42.81M $42.81M $17.43M
Total Long-Term Assets $1.466M $1.466M $917.0K
Total Assets $44.27M $44.27M $18.35M
YoY Change 141.3% 141.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.906M $2.030M $1.413M
YoY Change 34.89% 43.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $71.00K
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.104M $2.104M $1.635M
YoY Change 28.69% 28.69%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $668.0K $668.0K
YoY Change
Total Long-Term Liabilities $668.0K $668.0K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.104M $2.104M $1.635M
Total Long-Term Liabilities $668.0K $668.0K $0.00
Total Liabilities $2.772M $2.772M $1.635M
YoY Change 69.54% 69.54%
SHAREHOLDERS EQUITY
Retained Earnings -$39.90M -$27.20M
YoY Change 46.69% 54.55%
Common Stock $3.000K $1.000K
YoY Change 200.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $41.50M $41.50M $16.71M
YoY Change
Total Liabilities & Shareholders Equity $44.27M $44.27M $18.35M
YoY Change 141.3% 141.3%

Cashflow Statement

Concept 2022 Q4 2022 2021 Q4
OPERATING ACTIVITIES
Net Income -$12.65M -$12.60M -$9.666M
YoY Change 30.85% 30.35% 68.02%
Depreciation, Depletion And Amortization $64.00K $15.00K
YoY Change 113.33% 66.67%
Cash From Operating Activities -$11.46M -$3.989M
YoY Change 53.3% 30.96%
INVESTING ACTIVITIES
Capital Expenditures $394.0K $0.00
YoY Change -632.43%
Acquisitions
YoY Change
Other Investing Activities $0.00 $3.000K
YoY Change -100.0% -115.0%
Cash From Investing Activities -$394.0K $3.000K
YoY Change 603.57% -115.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $232.0K
YoY Change -99.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 36.96M -583.0K
YoY Change -6440.14% -102.67%
NET CHANGE
Cash From Operating Activities -11.46M -3.989M
Cash From Investing Activities -394.0K 3.000K
Cash From Financing Activities 36.96M -583.0K
Net Change In Cash 24.75M -4.569M
YoY Change -405.0% -124.34%
FREE CASH FLOW
Cash From Operating Activities -$11.46M -$3.989M
Capital Expenditures $394.0K $0.00
Free Cash Flow -$11.85M -$3.989M
YoY Change 60.16% 30.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
87000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
716000
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0313
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.0044
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001889109
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10274403
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24898908
CY2022 dei Document Type
DocumentType
20-F
CY2022 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41359
CY2022 dei Entity Registrant Name
EntityRegistrantName
Belite Bio, Inc
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
12750 High Bluff Drive Suite 475,
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
CY2022 dei Entity Address Country
EntityAddressCountry
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92130
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24898908
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Auditor Firm
AuditorFirmId
5395
CY2022 dei Auditor Name
AuditorName
Friedman LLP
CY2022 dei Auditor Location
AuditorLocation
New York, New York
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17344000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42089000
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
2000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
17431000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
42807000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
94000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
541000
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
31000
CY2021Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
815000
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8000
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
88000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
806000
CY2021Q4 us-gaap Assets
Assets
18348000
CY2022Q4 us-gaap Assets
Assets
44273000
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
71000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1564000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1906000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
198000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1635000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2104000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
668000
CY2021Q4 us-gaap Liabilities
Liabilities
1635000
CY2022Q4 us-gaap Liabilities
Liabilities
2772000
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
31806000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
492179086
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
492179086
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10274403
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24898908
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12325000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
81761000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-196000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-392000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27223000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39871000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-15093000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
41501000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18348000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44273000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3688000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7419000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8869000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2055000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2378000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3952000
CY2020 us-gaap Operating Expenses
OperatingExpenses
5743000
CY2021 us-gaap Operating Expenses
OperatingExpenses
9797000
CY2022 us-gaap Operating Expenses
OperatingExpenses
12821000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-5743000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-9797000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-12821000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
12000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
23000
CY2021 us-gaap Depreciation
Depreciation
30000
CY2022 us-gaap Depreciation
Depreciation
64000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
134000
CY2020 us-gaap Interest Expense
InterestExpense
21000
CY2022 us-gaap Interest Expense
InterestExpense
16000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
126000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
166000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
1363000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
131000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
173000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5752000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9666000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12648000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
CY2020 us-gaap Profit Loss
ProfitLoss
-5753000
CY2021 us-gaap Profit Loss
ProfitLoss
-9666000
CY2022 us-gaap Profit Loss
ProfitLoss
-12648000
CY2020 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
0
CY2021 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
0
CY2022 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
0
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
6000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-152000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-196000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5747000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9818000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12844000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8790397
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8790397
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9569932
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9569932
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19976596
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19976596
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.01
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.01
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-3739000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
500000
CY2020 blte Stock Issued During Period Value Conversion Of Other Payables To Related Parties
StockIssuedDuringPeriodValueConversionOfOtherPayablesToRelatedParties
500000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
86000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1363000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-5753000
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
6000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-7037000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
232000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1530000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-9666000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-152000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-15093000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
36146000
CY2022 blte Conversion Of Temporary Equity To Permanent Equity
ConversionOfTemporaryEquityToPermanentEquity
31806000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1483000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1530000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-12648000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-196000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
41501000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-5753000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-9666000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-12648000
CY2020 us-gaap Depreciation
Depreciation
17000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1483000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
8000
CY2020 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-4000
CY2022 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
32000
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-192000
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
35000
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
641000
CY2020 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-19000
CY2021 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
45000
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-41000
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-254000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
632000
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
373000
CY2020 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-8000
CY2021 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
2000
CY2022 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
79000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
71000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4442000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7474000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11458000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
74000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
394000
CY2020 blte Prepayments To Acquire Property Plant And Equipment
PrepaymentsToAcquirePropertyPlantAndEquipment
20000
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
18000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-56000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-394000
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
815000
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1030000
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
131000
CY2020 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2450000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
500000
CY2020 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
29792000
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
37990000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
86000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
232000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28059000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-583000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36963000
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-161000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-366000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23601000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8274000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24745000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2017000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25618000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17344000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25618000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17344000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42089000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
19000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
16000
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2014000
CY2020 blte Conversion Of Other Payable Due To Related Parties Into Ordinary Shares
ConversionOfOtherPayableDueToRelatedPartiesIntoOrdinaryShares
500000
CY2022 us-gaap Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
31806000
CY2022 blte Deferred Initial Public Offering Costs Reclassed To Additional Paid In Capital
DeferredInitialPublicOfferingCostsReclassedToAdditionalPaidInCapital
1844000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
941000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17600000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27200000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39900000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-5800000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-9700000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-12600000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42100000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our financial statements and accompanying notes. Significant accounting estimates reflected in the Company’s consolidated financial statements include, but are not limited to, valuation of ordinary shares, share options, valuation allowance for deferred income tax assets, useful lives for property and equipment, right-of-use (“ROU”) assets, operating lease liabilities and share-based compensation. Management bases the estimates on historical experience and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Accordingly, actual results could differ from those estimates.</p>
CY2021Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
815000
CY2022Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
0
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1844000
CY2022 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q2 blte Conversion Of Temporary Equity To Permanent Equity In Shares
ConversionOfTemporaryEquityToPermanentEquityInShares
7820914
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
14000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
497000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
50000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
202000
CY2021Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
23000
CY2022Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
17000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
87000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
716000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
47000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
91000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
94000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
541000
CY2020 us-gaap Depreciation
Depreciation
17000
CY2021 us-gaap Depreciation
Depreciation
30000
CY2022 us-gaap Depreciation
Depreciation
64000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
216000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
158000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
86000
CY2021Q4 blte Accrued Expenses For Research And Development Current
AccruedExpensesForResearchAndDevelopmentCurrent
741000
CY2022Q4 blte Accrued Expenses For Research And Development Current
AccruedExpensesForResearchAndDevelopmentCurrent
891000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
525000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
287000
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
147000
CY2022Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
272000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
56000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
382000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
95000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
74000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1564000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1906000
CY2022Q2 blte Conversion Of Temporary Equity To Permanent Equity In Shares
ConversionOfTemporaryEquityToPermanentEquityInShares
7820914
CY2021Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
7820914
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
7820914
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
7820914
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
31806000
CY2021Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
31806000
CY2021Q4 us-gaap Preferred Stock Convertible Shares Issuable
PreferredStockConvertibleSharesIssuable
7820914
CY2022 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.06
CY2022Q4 us-gaap Preferred Stock Convertible Conversion Ratio
PreferredStockConvertibleConversionRatio
1
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
41736
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
911000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
45000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1363000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1530000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1483000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
941000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
941000
CY2022Q2 blte Lessee Operating Lease Incremental Borrowing Rate
LesseeOperatingLeaseIncrementalBorrowingRate
0.0248
CY2022Q3 blte Lessee Operating Lease Incremental Borrowing Rate
LesseeOperatingLeaseIncrementalBorrowingRate
0.0264
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
806000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
198000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
668000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
866000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
134000
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0251
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P51M
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
218000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
233000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
866000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-331000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-413000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1097000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1266000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-5421000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-9253000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-11551000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5752000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9666000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12648000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.1832
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.1585
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.0956
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0040
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0030
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0060
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0003
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0033
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.0026
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.0020
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.0333
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.0532
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.0935
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0002
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
86000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
169000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2398000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1352000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2567000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1352000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2567000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
492179086
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
492179086
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022 blte Common Stock Votes Per Share
CommonStockVotesPerShare
1
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5753000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9666000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12648000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8790397
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8790397
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9569932
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9569932
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19976596
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19976596
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.01
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.01
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11216812
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9803475
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3576403

Files In Submission

Name View Source Status
blte-20221231_cal.xml Edgar Link unprocessable
blte-20221231_def.xml Edgar Link unprocessable
0001104659-23-040145-index-headers.html Edgar Link pending
0001104659-23-040145-index.html Edgar Link pending
0001104659-23-040145.txt Edgar Link pending
0001104659-23-040145-xbrl.zip Edgar Link pending
blte-20221231.xsd Edgar Link pending
blte-20221231x20f.htm Edgar Link pending
blte-20221231x20f002.jpg Edgar Link pending
blte-20221231x20f003.jpg Edgar Link pending
blte-20221231x20f004.jpg Edgar Link pending
blte-20221231x20f005.jpg Edgar Link pending
blte-20221231x20f006.jpg Edgar Link pending
blte-20221231x20f007.jpg Edgar Link pending
blte-20221231x20f008.jpg Edgar Link pending
blte-20221231x20f009.jpg Edgar Link pending
blte-20221231x20f010.jpg Edgar Link pending
blte-20221231x20f011.jpg Edgar Link pending
blte-20221231x20f012.jpg Edgar Link pending
blte-20221231x20f019.jpg Edgar Link pending
blte-20221231x20f020.jpg Edgar Link pending
blte-20221231xex12d1.htm Edgar Link pending
blte-20221231xex12d2.htm Edgar Link pending
blte-20221231xex13d1.htm Edgar Link pending
blte-20221231xex13d2.htm Edgar Link pending
blte-20221231xex15d1.htm Edgar Link pending
blte-20221231xex15d1001.jpg Edgar Link pending
blte-20221231xex15d2.htm Edgar Link pending
blte-20221231xex15d2001.jpg Edgar Link pending
blte-20221231xex2d6.htm Edgar Link pending
blte-20221231xex8d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
blte-20221231_lab.xml Edgar Link unprocessable
blte-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
blte-20221231x20f_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending